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Patient-Specific Stress–Abdominal Pain Interaction in
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Sampling Method Study
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Magnus Simre´n, MD, PhD4, Qasim Aziz, PhD, FRCP5, Maura Corsetti, MD, PhD6, Jan Tack, MD, PhD7, Zlatan Mujagic, MD, PhD1,
Carsten Leue, MD, PhD8, Joanna W. Kruimel, MD, PhD1 and Ad A.M. Masclee, MD, PhD1
INTRODUCTION: Gastrointestinal symptoms in irritable bowel syndrome (IBS) have been correlated with psychological
factors using retrospective symptom assessment. However, real-time symptom assessment might
reveal the interplay between abdominal and affective symptoms more reliably in a longitudinal
perspective. The aim was to evaluate the association between stress and abdominal pain, using the
Experience Sampling Method (ESM) as a real-time, repeated measurement method.
METHODS: Thirty-seven patients with IBS (26women;meanage36.7 years) and36healthy controls (HC; 24women;
meanage31.1 years) completedan electronic ESMduring7 consecutive days. Abdominal pain and stress
were scored on an 11-point Numeric Rating Scale at a maximum of 10 random moments each day.
RESULTS: Abdominal pain scores were 2.21 points higher in patients with IBS compared with those in HC (P <
0.001),whereas stress levels didnot differ significantly (B: 0.250,P50.406). In IBS, a1-point increase
in stresswas associatedwith, onaverage,0.10points increase in abdominal pain (P50.017). InHC, this
was only 0.02 (P5 0.002). Stress levels at t521 were not a significant predictor for abdominal pain at
t5 0 in both groups, and vice versa.
DISCUSSION: Our results demonstrate a positive association between real-time stress and abdominal pain scores and
indicate a difference in response to stress and not a difference in experienced stress per se.
Furthermore, an in-the-moment rather than a longitudinal association is suggested. This study
underlines the importance of considering the individual flow of daily life and supports the use of real-
time measurement when interpreting potential influencers of abdominal symptoms in IBS.
Clinical and Translational Gastroenterology 2020;11:e00209. https://doi.org/10.14309/ctg.0000000000000209
INTRODUCTION
Irritable bowel syndrome (IBS) is a disorder of gut–brain in-
teraction, in which psychological factors play a role in both
symptom origination and perpetuation (1). Associations be-
tween anxiety and depression and IBS have extensively been
studied, but daily stress and life hassles have also been associated
with gastrointestinal (GI) symptoms in IBS (2,3). However,
whether those psychological features precede or follow the
occurrence of GI symptoms remains to be elucidated (4,5).
Furthermore, it is likely that the order of occurrence of these
symptoms and the magnitude of the association between both
differ between subjects. Further unraveling this association by
considering the heterogeneity between patients with IBS could
give insight in individual interactions between psychological
and GI symptoms, leading the way to a more personalized ap-
proach of IBS.
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Most previous studies on this issue are either cross-sectional
studies that concurrently assessed both psychological and GI
symptoms for between-subject analyses or longitudinal studies
that reported within-subject analyses based on repeated assess-
ments on daily or weekly basis (6–8). Although the latter meth-
odology offers a better opportunity to analyze the relationship
between both symptoms over time, it does not take into account
the individual daily life flow of symptom interactions.
IBS has been described to present as a relapsing-remitting dis-
order, with symptoms varying over time, where highly fluctuating
symptompatterns are often even reportedwithin 1 day (9,10). This
underlines the importance of considering this daily life symptom
variability when evaluating associations with possible triggering or
concomitant factors, such as stress. In addition, as is true for the
assessment of abdominal pain (11,12), end-of-week or end-of-day
reports of stress are likely influenced by recall bias because stress
(i.e., regarding daily life hassles) is a complex process subject to
within-day fluctuations (13,14). This further emphasizes the need
for studying the temporal interplay between stress and GI
symptoms.
For this purpose, we previously developed an electronic
smartphone-based patient-reported outcome measure specifi-
cally for the use of the Experience Sampling Methodology (ESM)
in populations with IBS (15). The ESM is a momentary assess-
ment method collecting repeated measurements randomly dur-
ing the day, which concern the current status and natural
environment of the subjects. These repeated in-the-moment as-
sessments result in an extensive individual pattern of symptoms
and provide insight into the complex interplay between this
longitudinal symptom formation and possibly associated daily
life factors.
Chan et al. (16) recently reported results of an ESM study
evaluating the temporal relationship between psychological fac-
tors and bowel symptoms in patients with IBS with predominant
diarrhea (IBS-D) and healthy volunteers. An interesting finding
was a negative association between abdominal pain and pre-
ceding stress levels, whereas abdominal pain was predictive for
the occurrence of daily life stress and negative effect. In this re-
port, a potential association between concurrent abdominal and
psychological symptoms was not evaluated, whereas Blanchard
et al. (6) previously pointed toward an important association as
such using daily reports.
Therefore, the aim of this study was to evaluate the associ-
ation between stress and abdominal pain, using concurrent and
time-lagged assessments, in patients with IBS and healthy
controls (HC), using the ESM. A detailed interpretation of the
association between daily life stress and abdominal pain on the
subject level, taking into account between-subject heterogene-
ity, is provided.
METHODS
This prospective observational study was executed as part of a
larger international, multicenter project. This report presents
data of 1 center, the Maastricht University Medical Center1
(Maastricht UMC1), Maastricht, the Netherlands. The study
protocol has been approved by the Maastricht UMC1 Com-
mittee of Ethics inNovember 2016 andwas executed according to
the tenets of the revised Declaration of Helsinki (64th World
Medical Association General Assembly, Fortaleza, Brazil; Octo-
ber 2013). The study has been registered in the US National Li-
brary ofMedicine (http://www.clinicaltrials.gov, NCT02880722).
Study participants
Recruitment of patients with IBS, aged between 18 and 70 years,
took place at the outpatient clinic of Gastroenterology-Hepatology
of Maastricht UMC1, a secondary/tertiary referral center. In ad-
dition, subjects who previously participated in the Maastricht IBS
Cohort (17–19) were contacted to participate in this study. IBS,
including subtype assignment, was diagnosed according to the
Rome IV criteria (20,21), whichwere evaluated by a trained clinical
researcher in a face-to-face interview. Reason for exclusion was
abdominal surgery in the past (except for uncomplicated appen-
dectomy, cholecystectomy, and/or hysterectomy).
HC, also aged between 18 and 70 years, were recruited through
advertisements in Maastricht UMC1. Subjects were eligible if they
did not have a past or present diagnosis of any GI disorder and did
not fulfill Rome IV criteria for IBS. All study subjects could only
participate if they could understand the Dutch language and were
able to use the smartphone application. Subjects who did not have a
smartphone but able to run the applicationwere provided a suitable
device for the duration of the study period. Participants were not
allowed to change their medication use or start any non-
pharmacological treatment within 1month before the start of study
participation until the end of the study period. All subjects gave
written informed consent before participation.
Data collection
All study participants completed the ESM for 7 consecutive days
during their regular daily life. A digital application (Maastricht
Electronic Abdominal Symptom REcording [MEASuRE]), which
was specifically developed for the use of ESM in patients with IBS
(15), was downloaded on the participants’ smartphones and was
activated for the course of the study period. Subjects were
instructed to carry their smartphone with them during the study
week and to complete the real-time questionnaires as often as
possible. The MEASuRE application was set to send out an audi-
tory andwritten signal 10 times a day at randommoments between
07:30 AM and 10:30 PM, with at least 15minutes and amaximumof
3 hours between subsequent signals. Every 10 minutes after a sig-
nal, the ESMquestionnaire was available. Questionnaires that were
not completed within 10 minutes after a signal were considered
missing data. Therefore, subjects were instructed to complete as
many questionnaires as possible each day, as soon as possible fol-
lowing each signal, but to skip questionnaires when considering
completing impossible at that moment (e.g., when driving a car).
Previous studies using this specific ESM algorithm have shown
reasonably high completion rates (11,22).
The development of this ESM questionnaire for the momentary
assessment of GI symptoms, the affective state, and environmental
factors was described previously (15). This questionnaire was repeated
in the same order at all measurement moments, and questions were
scoredonan11-pointNumericRatingScale (05notatall to105very
severely), according to the U.S. Food and Drug Administration (FDA)
and European Medicines Agency (EMA) recommendations (23,24).
Figure 1 shows a screenshot of theMEASuREapplication for the items
“abdominal pain” and “stress,” that were used in the current analyses.
At the end of the 7-day study period, the Patient Health
Questionnaire (PHQ)-9 (0–3 scale; calculates a total composite
score for severity of depressive symptoms; recall period of 2 weeks)
(25), Generalized Anxiety Disorder (GAD)-7 (0–3 scale; calculates
a total composite score for severity of anxious symptoms; recall
period of 2 weeks) (26), and the Visceral Sensitivity Index (VSI)
were completed (27,28). The 15-item VSI assesses GI-specific
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anxiety ona 6-point Likert scale.A composite sumscore of all items
was calculated; higher scores indicated more GI-specific anxiety.
The item “In stressful situations, my belly bothers me a lot” was
used in this study as the self-reported association between stress
and abdominal symptoms.
Statistical analysis
All analyses were performed using R version 3.5.1 (R Core Team
[2018]. R: A language and environment for statistical computing.
R Foundation for Statistical Computing, Vienna, Austria). Con-
tinuous outcomes are presented as mean 6 SD, and differences
between groups were tested using the independent samples t test.
Proportions for categorical variables were tested using the x2 test.
A P value of ,0.05 was considered statistically significant. Sub-
jects who completed at least one-third of the total number of
assessments (i.e., 23 of 70)were included in the analyses regarding
ESM data (29,30).
Levels of abdominal pain and stress over the 7-day study pe-
riod were compared between patients with IBS and HC using
linear mixed-effects models because ESM data are hierarchical
with repeated measures (level 1) nested within subjects (level 2).
ESM scores (i.e., abdominal pain or stress) were used as the de-
pendent variable and disease status (i.e., IBS or healthy) as the
predictor variable. Models were corrected for repeated measures
and autocorrelation using an autoregressive covariate (AR1)
structure.
To evaluate associations between stress and abdominal pain,
similar analyses were performed. First, the association between
concurrent stress and abdominal pain was evaluated, using ab-
dominal pain scores as dependent and stress scores as independent
variables. A first model including the total study population in-
cluded the interaction between stress and disease status as a pre-
dictor variable.Whenfinding a significant association between this
interaction term and abdominal pain scores, models were per-
formed separately for patients with IBS andHC to further evaluate
the association between stress and abdominal pain in each group.
Because itwas a priorihypothesized that stress and abdominal pain
would particularly be related in subgroups of patients with IBS, the
model was performed separately for eachpatient with IBS to obtain
individual regression coefficients.
Second, we assessed whether stress scores at 1 point in time
could predict subsequent abdominal pain scores, by using lagged
scores (i.e., t 5 21) of stress as the predictor variable. Similarly,
lagged scores for abdominal pain were tested as predictor variables
in models with stress scores as the dependent variable to assess a
possible association between stress scores and preceding abdomi-
nal pain scores. In allmodels, randomslopes for predictor variables
were tested, but the models with the best model fit (i.e., based on
Akaike Information Criterion) are reported in this study.
RESULTS
Study population
Thirty-seven patients with IBS and 36 HC were enrolled and
completed the study. Female sex was predominant in both groups
(70% in IBS and67% inHC), andmeanagewas 36.7613.6years in
the IBS group and 31.26 17.7 years in HC. These characteristics
were not significantly different between the groups. In the IBS
group, IBS subtypes were represented as follows: 14 diarrhea pre-
dominant (IBS-D), 10 constipation predominant, 8 mixed stool
pattern, and 5 undefined predominant stool pattern. In both IBS
andHCgroups,most subjects scored onlyminimal ormild for both
depressive (PHQ-9) and anxious (GAD-7) symptoms, i.e., total
PHQ-9 or GAD-7 score of 0–9. These scores were not significantly
different between thegroups.Completion rateof ESMwas 68.6% in
the IBS group and 69.4% in the control group. All subjects com-
pletedat least one-thirdof the total numberof assessments (70) and
were, therefore, all included in the analyses.
Levels of abdominal pain and stress
Overall, mean abdominal pain scores from day to day were sig-
nificantly higher in the IBS group than pain scores reported by the
HC. On average, patients with IBS reported abdominal pain scores
of 2.21 points higher compared with HC (SE: 0.27, P , 0.001).
However, mean stress levels were not significantly different be-
tween the groups (mean difference: 0.25, SE: 0.30, P 5 0.406)
(Figure 2).
Association between stress and abdominal pain scores
In the IBS group, a significant association was found between
concurrent stress and abdominal pain scores.On average, a 1-point
increase in stress was associated with 0.10 points increase in ab-
dominal pain (SE: 0.04, P5 0.017). In HC, this was only 0.02 (SE:
0.01, P 5 0.002). Figure 3 visualizes the repeated measures for
abdominal pain and stress over the 7-day study period, separately
for 3 of the patients with IBS, which were selected to illustrate
between-subject differences in the association between stress and
abdominal pain. The plots show that the interplay between stress
and abdominal pain is different for each of the 3 individuals. This is
Figure 1. Screenshots of ESM questions for the assessment of abdominal pain (a) and stress (b). Questions were phrased in Dutch; in this study, it is
translated into English.
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Stress–Abdominal Pain Interaction in IBS 3
confirmed when performing the above-described linear mixed-effects
model, separately for each patient with IBS: the coefficients for the
association between stress and abdominal pain range from 21.92 to
1.56. This means that, in 1 subject, a 1-point increase in stress corre-
sponded to a decrease in abdominal pain of 1.92 points, whereas in
another, thiswasassociatedwith1.56points increase inabdominalpain.
Stress levels at t521 (i.e., lagged scores)were not a significant
predictor for abdominal pain at t 5 0 in both patients with IBS
and HC. Similarly, abdominal pain scores at t 5 21 could not
predict stress levels at t5 0 in both groups.
Agreement with self-reported association between stress and
IBS symptoms
The VSI item “In stressful situations, my belly bothers me a lot”
can be interpreted as a representation of the subjectively experi-
enced association between stress and GI symptoms (subjective
association). If this correspondswell with the association as found
in the current real-time ESM data (objective association), this
would indicate that subjects are able to retrospectively report an
association between stress and abdominal pain reliably.
In total, 81.1% of the subjects reported to have more GI symp-
toms during stressful situations to some extent (i.e., answering
options “mildly agree,” “moderately agree,” or “strongly agree”).
More thanhalf of the studypopulation (54.1%) strongly agreedwith
this statement. As described earlier, we found large heterogeneity in
themagnitudeof the association between stress and abdominal pain
when assessing the real-time ESM data (objective association).
Together with a correlation coefficient of only 0.125 between the
subjective (i.e., VSI) and the objective (i.e., ESM) association, this
suggests that patients with IBS retrospectively report an association
between stress and abdominal pain as more important compared
with when momentary assessed during daily life.
DISCUSSION
This ESM study demonstrates that concurrent levels of stress and
abdominalpainareassociated inpatientswith IBSbutnot inHC.High
heterogeneity in themagnitude of this associationwas found, pointing
toward different levels of stress sensitivity within the population with
IBS. Although average abdominal pain scores over 7 days were sig-
nificantly higher in patients with IBS compared with HC, stress levels
did not differ between the groups. An association between stress and
preceding abdominal pain scores could not be confirmed, and neither
were stress levels predictive for subsequent abdominal pain scores. In
addition, a subjectively reported relationship between stress and GI
symptoms, represented by the VSI, was not in agreement with the
association as found within the ESM data, suggesting overestimation
of the role of stress in retrospective self-reported questionnaires.
As expected, reported abdominal pain was on average signifi-
cantly lower in the HC compared with individuals diagnosed with
IBS. By contrast, momentary stress levels were not significantly
different over time between patients with IBS and their non-IBS
counterparts. Both findings are consistent with a recent ESM study
of Chan et al. (16) in patients with IBS-D. In addition to this, we
could demonstrate a significant and clinically relevant association
between stress levels and concurrent abdominal pain scores in the
IBSbutnot the healthy group,which suggests that patientswith IBS
do not experience more stress per se but seem to be more suscep-
tible to a greater impact of feeling stressedduringdaily life. This has
been described previously in the context of early life stress events
(31,32). It has been suggested that the association could work the
Figure 2. Symptom severity for abdominal pain and stress over the 7-day study period, separately for patients with irritable bowel syndrome and healthy
subjects. Symptom scores are measured using ESM over 7 days; mean scores per day are presented. NS, not significant.
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other way around as well; in that case, abdominal pain would lead
to (increasing) stress (2,7,33). This would most likely have been
reflected by higher stress levels in patients with IBS compared with
the control population, but because both abdominal pain and stress
are transient symptoms, particularly in the context of momentary
assessment, this effect could have been not apparent in the mean
scores as presented. This ESM analyses do not allow us to draw
conclusions for a causal relation, but based on the above-
mentioned considerations, we assume that stress triggers the on-
set or worsening of abdominal pain in patients with IBS.
An interaction between concurrent stress and abdominal pain
as suchwas previously demonstrated in a report by Blanchard et al.
(6), in which weekly averages of daily symptom scores were ana-
lyzed. This study adds evidence to this by exploring short-term
associations in more detail, that is, within the day. Our results
underline that even within-day changes in stress can be associated
with daily fluctuations in abdominal pain, of which the pattern
could be overlooked when only analyzing on week level. This also
illustrates the temporality of stress and abdominal pain, and the
complexity of the interaction between the both over time, which
Figure3.Symptomseverity scores for abdominal painandstress, on70 random timepoints over 7days, separately for 3 subjectswith IBS.The xaxis represents
the70consecutive assessments: eachwithin a90-minute timeframebetween7:30AMand10:30 PM for eachday (day1:1–10;day2: 11–20;day3: 21–30;day
4: 31–40; day 5: 41–50; day 6: 51–60; and day 7: 61–70). The heterogeneity between subjects with IBS is shown by the different patterns of stress and
abdominal pain; also indicated by the difference in corresponding regression coefficients for (a)20.23, (b) 0.07, and (c) 0.28. IBS, irritable bowel syndrome.
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Stress–Abdominal Pain Interaction in IBS 5
should be considered when evaluating these symptoms in patients
with IBS. Furthermore, we demonstrate high heterogeneity in the
magnitude of the association between subjects, which points
toward different levels of stress sensitivity regarding a stress–
abdominal pain interaction within the patients with IBS. One ex-
planation for this could be that each individual has different
mechanismsof copingwith stress (34). Thisfinding emphasizes the
need for an individualized approach in both research and clinical
management regarding IBS. In addition, about understanding the
impact of stress on IBS pain symptoms, future analyses of mo-
mentary assessment should be aimed at more in-depth analysis of
contextual and ecological factors (including food intake), whichwe
were currently unable toperform inameaningfulmatter becauseof
the fairly small sample size and the heterogeneity of the data.
Daily life stress did not predict subsequent abdominal pain
scores, or vice versa, contradicting the findings of Chan et al. (16).
Although, in this recent study, daily life stress was represented by the
stressfulness of the major activity that took place since the previous
entry, we used the scoring of to what extent a subject felt stressed at
the current entry. Similarly, the reporting of abdominal pain was
different: Chan et al. analyzed to what extent abdominal pain be-
tween the current and previous timepoint had affected the subject’s
daily activity, whereas our participants scored their abdominal pain
on each assessment moment using an 11-point Numeric Rating
Scale. These methodological differences in definitions of daily life
stress and abdominal pain and the time span to which the assess-
ments refer (i.e., “between the previous and current assessments” vs
“at the current assessment”) might, therefore, be a reason for dif-
ferences in results. Furthermore, slightly different timing of the as-
sessments (i.e., 8 times aday for 14 consecutive days vs 10 times aday
for 7 consecutive days) combined with unavoidable differences in
missing data might lead to alterations in the time lags. Future re-
search might benefit from taking into account the exact length of
time between assessments, herewith providing a more reliable
comparison between studies. Even though we did not find any sig-
nificant associations in time-lagged analyses, this does not fully reject
the potential presence of interactions as such, possibly only in a
subgroupofpatientswith IBS.Lastly, the inclusionof all IBS subtypes
compared with only IBS-D in the study of Chan et al. could explain
differences between the studies. For instance, patients with IBS ex-
periencing diarrhea and urgency compared with those with con-
stipation, straining, and a feeling of incomplete evacuation could be
characterized by different stress–pain relationships and the tempo-
rality of these interactions could also be different. The current data
lack statistical power to perform any subtype-specific analyses, but
future studies might look into differences in stress–abdominal pain
interaction between IBS subtypes.
The disagreement between a self-reported relationship (using
the VSI) between stress and abdominal pain and the association
between these factors in ourmomentary data (usingESM) suggests
that subjects do not reliably report this interplay between symp-
toms in retrospective questionnaires. This could be due to recall
bias in which our autobiographical memory is not able to correctly
recall the exact interaction between experiences. The reporting of
peak rather than average levels of abdominal pain in patients with
IBShas been linked to retrospective assessments in previous studies
(10,11), which might also hold true for the stress–abdominal pain
association. Being aware of the fact that patients might overreport
an effect of stress on their abdominal symptoms is relevant for
clinicians because subjects showing a considerable stress-related
pain response might benefit from different management strategies
than others (3). In addition, patients might benefit from education
for providing insight into their individual, moment-to-moment
flow of both psychological and abdominal symptoms, herewith
creating awareness for their disease course and assisting thera-
peutic approaches such as cognitive behavioral therapy.
This study demonstrates that ESM is suitable to more deeply
characterize individual symptom patterns using repeated, mo-
mentary assessments and taking into account psychosocial factors
in patients with IBS. The inclusion of a HC group puts extra
confidence to the conclusion that the presented results are
reflecting the population with IBS, and by considering all 4 IBS
subtypes, the results become generalizable to the heterogeneous
population with IBS as a whole. Data were collected using a pre-
viously validated IBS-specific ESM tool that was developed
according to FDA guidelines for the development of patient-
reported outcome measures (15). All statistical models were cor-
rected for autocorrelation of which the importance in this specific
context was previously underlined by Blanchard et al. (6).
An inevitable limitation of using the ESM is the occurrence of
missing data. However, this is accounted for as much as possible
by only including subjects who complete at least one-third of the
total number of assessments and by using advanced statistical
modeling correction for repeated measures and within-subject
autocorrelation. The inclusion of subjects in a secondary/tertiary
center might result in a specific study population not fully gen-
eralizable to the entire population with IBS. However, subjects
were previously also recruited through general practitioners’
practices (i.e., for the Maastricht IBS Cohort), so this study
population most likely represents a heterogeneous population
with IBS. Furthermore, selection bias could have arisen by the fact
that ESM might be experienced as burdensome. Because the
current report only includes data from 1 of the 5 intended in-
clusion centers, sample size is relatively small, which impacts the
strengths of the conclusions drawn from this analysis. Future
analyses including more subjects, from different centers, could
give additional insight into the heterogeneity in stress–abdominal
pain interaction between subjects and between IBS subtypes and
allow for assessment of cross-cultural differences.
In conclusion, using real-time symptom assessment, we
demonstrated that stress levels are positively associated with
concurrent abdominal pain scores, with high heterogeneity in the
magnitude of this association between individual patients with
IBS, pointing toward different levels of stress sensitivity regarding
stress–abdominal pain interaction in IBS. Although patients with
IBS and HC showed comparable levels of stress, the association
between abdominal pain and stress was stronger in patients with
IBS comparedwith that inHC, indicating a difference in response
to stress rather than a difference in experienced stress per se. In
addition, abdominal pain scores could not be predicted by pre-
ceding stress levels, and vice versa, suggesting an in-the-moment
rather than a longitudinal association. This study underlines the
importance of taking into account the individual flow of daily life
when evaluating symptom patterns in patients with IBS and
supports the use of real-time measurement when interpreting
potential influencers of abdominal symptoms.
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